美西拉宗
|
|
- CAS号:
- 29053-27-8
- 英文名:
- Meseclazone
- 英文别名:
- W-2395;NSC297623;Meseclazone;7-Chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo[3,2-b][1,3]benzoxazin-9-one;3,3a-Dihydro-7-chloro-2-methyl-2H,9H-isoxazolo[3,2-b][1,3]benzoxazin-9-one;7-chloro-2-methyl-3,3a-dihydro-2H-[1,2]oxazolo[3,2-b][1,3]benzoxazin-9-one;2H,9H-Isoxazolo[3,2-b][1,3]benzoxazin-9-one, 7-chloro-3,3a-dihydro-2-methyl-
- 中文名:
- 美西拉宗
- 中文别名:
- 美西拉宗;化合物 T16353
- CBNumber:
- CB21179138
- 分子式:
- C11H10ClNO3
- 分子量:
- 239.65
- MOL File:
- 29053-27-8.mol
|
|
|
美西拉宗化学性质
-
熔点:
-
148°C
-
|
-
沸点:
-
131.8°C (rough estimate)
-
|
-
密度:
-
1.3213 (rough estimate)
-
|
-
折射率:
-
1.5800 (estimate)
-
|
-
储存条件:
-
Store at -20°C
-
|
-
溶解度:
-
Soluble in DMSO
-
|
-
酸度系数(pKa):
-
-3.18±0.40(Predicted)
-
|
美西拉宗性质、用途与生产工艺
Meseclazone (W2395;NSC297623) 是一种非甾体抗炎药 (NSAID),具有抗炎,止痛和解热活性。
Meseclazone inhibits collagen-induced aggregation 1 and 4 hr after oral administration. Intravenous administration of Meseclazone and other nonsteroidal anti-inflammatory drugs caused a dose-dependent inhibition of bronchoconstriction resulting in the following order of descending potency: isoproterenol congruent to indomethacin greater than fenoprofen greater than tolmetin greater than aspirin greater than naproxen congruent to ibuprofen greater than phenylbutazone greater than diflunisal greater than Meseclazone greater than 5-CSA.
类别
有毒物质
毒性分级
中毒
急性毒性
口服- 大鼠 LD50: 1160 毫克/ 公斤; 口服- 小鼠 LD50: 2250 毫克/ 公斤
可燃性危险特性
可燃, 燃烧时分解有毒氯化物, 氮氧化物气体
储运特性
库房低温, 通风, 干燥
灭火剂
水, 二氧化碳, 干粉, 砂土
美西拉宗
上下游产品信息
上游原料
下游产品
29053-27-8, 美西拉宗 相关搜索:
- 化合物 T16353
- 美西拉宗
- 29053-27-8
- 2H,9H-Isoxazolo[3,2-b][1,3]benzoxazin-9-one, 7-chloro-3,3a-dihydro-2-methyl-
- 7-chloro-2-methyl-3,3a-dihydro-2H-[1,2]oxazolo[3,2-b][1,3]benzoxazin-9-one
- Meseclazone
- NSC297623
- W-2395
- 7-Chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo[3,2-b][1,3]benzoxazin-9-one
- 3,3a-Dihydro-7-chloro-2-methyl-2H,9H-isoxazolo[3,2-b][1,3]benzoxazin-9-one